US Broker Ratings

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A 121% Upside Potential Beckons

For investors with a keen eye on the biotechnology sector, Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing opportunity. With a market capitalization of $2.76 billion, this Redwood City-based biopharmaceutical..

Elanco Animal Health (ELAN): Investor Outlook with 10.35% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) continues to capture the attention of investors in the healthcare sector, particularly those focusing on the niche of drug manufacturers specializing in veterinary products...

HealthEquity, Inc. (HQY) Stock Analysis: 28% Upside Potential and Robust Analyst Consensus

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the Health Information Services industry, is capturing the attention of investors with its solid market presence and promising growth outlook. With a..

Doximity, Inc. (DOCS) Stock Analysis: Healthcare’s Digital Pioneer with a 49% Upside Potential

Doximity, Inc. (NYSE: DOCS) has carved a unique niche in the healthcare sector with its innovative digital platform tailored for medical professionals. As a company operating in the health information..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotechnology Powerhouse with 19.66% ROE

Krystal Biotech, Inc. (NASDAQ: KRYS), a rising star in the biotechnology sector, has captured investor attention with its impressive financial metrics and innovative genetic medicines. With a robust market capitalization..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

iRhythm Technologies, Inc. (IRTC): Investor Outlook with 23.68% Potential Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) is a standout player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $5.75 billion, iRhythm has carved out..

Regencell Bioscience Holdings (RGC): Unpacking the Dynamics of a $8 Billion TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands as a significant player in the healthcare sector, specifically within the niche of Traditional Chinese Medicine (TCM). With a market capitalization of $8.03..

Telix Pharmaceuticals Limited (TLX): Investor Outlook with a Promising 115.84% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX) is making waves in the biotechnology sector with its innovative approach to radiopharmaceuticals. As a commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, Telix is..

Guardant Health, Inc. (GH) Investor Outlook: Analyzing a 38.5% Revenue Growth in the Precision Oncology Space

Guardant Health, Inc. (NASDAQ: GH) has emerged as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $13.25 billion, this..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Analyzing a 20% Potential Upside in the CNS Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a notable player in the biotechnology sector, presents an intriguing opportunity for investors with its focus on developing cutting-edge therapies for central nervous system (CNS)..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Volatility in the Biotech Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) presents a compelling case study of the biotechnology industry’s inherent volatility. With its focus on developing groundbreaking RNA-targeted therapeutics and gene therapies, Sarepta is at..

Universal Health Services, Inc. (UHS): Stock Analysis Reveals Potential Upside and Strong Buy Ratings

Universal Health Services, Inc. (NYSE: UHS) has emerged as a compelling investment opportunity within the healthcare sector, especially for those with an eye on the medical care facilities industry. Headquartered..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with a 26% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a biopharmaceutical company hailing from Denmark, is making waves in the biotechnology sector with its innovative TransCon technology. With a market capitalization of $12.55 billion,..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Powerhouse With 362% Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is making waves in the biotechnology sector with its innovative approach to tackling metabolic diseases. Headquartered in West Conshohocken, Pennsylvania, Madrigal focuses on developing novel..

Qiagen N.V. (QGEN)

⚠️ No article content returned.

..

Masimo Corporation (MASI) Stock Analysis: Healthcare Innovator with a 29.69% Potential Upside

Masimo Corporation (NASDAQ: MASI) stands out in the healthcare sector, particularly within the medical devices industry, for its innovative approach to patient monitoring technologies. Headquartered in Irvine, California, Masimo has..

BridgeBio Pharma, Inc. (BBIO): Growth Potential with a 14.95% Upside Amidst Biotech Innovations

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its innovative approach to addressing genetic diseases and cancers. With a current market cap of $14.19 billion,..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unlocking Growth Potential with Innovative Treatments

Akero Therapeutics, Inc. (NASDAQ: AKRO), a promising player in the biotechnology sector, is gaining attention for its innovative approach to treating serious metabolic diseases. Headquartered in South San Francisco, California,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds